RAD50 and ovarian carcinoma: To determine the function of Rad50 in ovarian cancer, we established cell lines with Rad50 overexpression (Rad50‐OVE) or knockdown (shRad50) as illustrated in Figure S1D. We next performed clonogenic assay to evaluate the effect of Rad50 on ovarian cancer cells.